Member Info for TrickyEFC

Exman if finger up ya bum and you fooked each other have a baby you could train him to assassinate Levi.

you guys are more consistent than enet placings.

Just how much have you two lost, ya must be up there with skid.

I can currently sell at a higher price than I can buy. 🤔

that £22.55k trade at a premium 1499p

not first time someone paying a premium for decent size.

lots of positive ****

to the **** pot at

8.09am selling ******* after that rns.

fook me can't wait for the sellers at 16 to be exhausted.

should be done surely

Ok 740 is not over half of 1.5 bil 😂 but it's fooking good going is the point 😂

740 mill traded since the 22nd. That's over half of the new available shares. Remember the rest are held by awakn holders so only 1.5 bill extra.

Reckon mello last week was a smash hit

Dv the ask is 50% above the original ipo last year and is just getting started 💪💪💪

and jon cena can't handle the truth.

nice rns this morning. how do others do 100% on less ****tier rns.

let motor on up

Nice to see that blue ink

16:31:02 0.14 17,500,000 Sell* 24.50k

Nice buy too end the week

I thought this sounding promising from last summer but nothing since.

The Company is pleased to announce the grant of patent P-202400066, titled "Dual hydrogel multi-crosslinking haemostatic composition and method of manufacturing thereof", to further strengthen the Company's IP portfolio.

The disclosed dual hydrogel multi-crosslinking haemostatic composition offers a groundbreaking solution for emergency haemostasis by amalgamating two distinct gels, each possessing unique cross-linking mechanisms and bioactive components. Gel A, containing sodium carboxymethylcellulose (Na-CMC) and tranexamic acid (TXA), is ionically cross-linked with calcium ions (Ca+), while Gel B, comprising cationic carboxymethyl chitosan (CMCS) and sodium alginate (Na-Alginate), undergoes electrostatic and ionic cross-linking with boron ions (B-).

Stored separately but applied together using a dual-chamber syringe, these gels intermix at the bleeding site, facilitating immediate formation of a final hydrogel with enhanced mechanical properties and adhesive strength.

This composition fulfils the imperative for effective, user-friendly haemostatic agents in emergency settings, offering biocompatibility, antibacterial properties, and pro-healing effects, thereby presenting a versatile solution for various surgical procedures, trauma care, and veterinary medicine, while also serving as a potential scaffold for tissue engineering or drug delivery.

Anthony Tennyson, CEO, commented:

"The global emergency hemostasis products market is significant and growing, and the grant of this patent underscores the potential of our Graft Bio division. With our enhanced hemostasis IP portfolio, we are well-equipped to address the evolving needs of healthcare professionals and patients in this segment. Concurrently, we are actively pursuing our previously announced review of the Company's operations to identify additional opportunities for growth

Not Dennis meant David news sorry

With the mellow conference and Dennis news this week not a bad week at all

Solid on the bid of 14 and very small spread

Nice TTC.

All buys think last sell was at 10.13am

Don't know much but with a big green bull graphic and multi bag of the year he seems sound 💪

Daffy ya wish has held up for an hour

Llama inam.hpping to be in the 0.4 before the proper news starts to flow. £30 mill for what's currently on offer is a more fair valuation for where we currently stand.

The disconnect is bonkers

With all the mini bounces here can't be many left to sell at 16 can there

16:29:58 0.1645 1,495,154 Buy* 2,460

Last buy yesterday. We are already blue I'm reality 😂😂😂